Luminous Medical Inc.
This article was originally published in Start Up
Luminous Medical Inc. aims to meet the growing demand for tighter glucose control in hospital settings with automatic continuous blood glucose monitoring technology. Eventually, the company plans to use its CBGM platform as the cornerstone of a closed-loop glucose control system for hospitalized patients.
You may also be interested in...
Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving patient outcomes. Today, a small pack of companies is trying to finally deliver on the promise.
Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving outcomes. Today, GlySure and others are working on continuous glucose monitoring for the critical care environment to help deliver on that promise.
A new market in hospital intensive care units has opened up for companies glucose monitoring technologies and it represents a double-digit growth opportunity both for companies with continuous glucose monitors and critical care franchises. As partners,, Edwards Lifesciences and Dexcom bring both the marketing and technological strengths to successfully compete in this new market.